Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will...
Presentations Will Feature Studies Evaluating TENEOโข Excimer Laser Platform, MIEBOยฎ (Perfluorohexyloctane Ophthalmic Solution) and enVistaยฎ Envy...
Richard De Schutter to Retire from Board Following 2024 Annual Meeting Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health...
Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying...
Fourth-Quarter 2023 Financial Results Revenue of $1.173 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $54 Million Adjusted...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.